EFFECT OF ADENOVIRUS E3 IMMUNOREGULATORY PROTEIN ON ALLOGENIC TRANSPLANTATION
EFFECT OF ADENOVIRUS E3 IMMUNOREGULATORY PROTEIN ON ALLOGENIC TRANSPLANTATION
批准号:
6564319
负责人:
MARSHALL S. HORWITZ
金额:
$18.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-12-01 至 2003-11-30
关键词:
Adenoviridae MHC class I antigen NOD mouse diabetes mellitus diabetes mellitus therapy disease /disorder prevention /control genetically modified animals homologous transplantation immediate early protein immunomodulators lymphocyte microorganism immunology nonhuman therapy evaluation pancreatic islet transplantation transplantation immunology tumor necrosis factor alpha
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human adenoviruses (Ads) encode a number of proteins that modulate
the host responses against virus-infected cells. These proteins, whose
genes are clustered in the early region 3 (E3) transcription unit, can (1)
control transport of the class I major histocompatibility complex (MHC)
heavy chain from the endoplasmic reticulum (ER) to the cell surface and
(2) inhibit cytolysis induced by tumor necrosis factor alpha (TNFalpha).
We postulated that the anti-class I MHC and anti-TNF effects of the Ad E3
genes may be used to facilitate allogenic pancreatic beta-cell
transplantation and prevent autoimmune diabetes. Experiments have been
performed in transgenic mice carrying the entire Ad2 E3 transcription
region behind the rat insulin promoter (RIP) to test these hypothesis.
Both tolerization to long-term allogeneic transplantation and prevention
of lymphocytic choriomeningitis virus (LCMV)-induced autoimmune diabetes
have been achieved in the presence of the Ad E3 transgenes expressed in
islets. Encouraged by these initial results, we wish to extend these
observations into new area of investigation by studying the contributions
of individual Ad E3 gene products in the transplantation and LCMV models
as well as introduce the Ad E3 immunoregulatory gene functions into the
islets of nonobese diabetic (NOD) mice. The Ad E3 genes will also be
inserted into a conditionally immortalized and growth controlled murine
beta-cell line for the long term correction of diabetes by allogeneic
transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of ELANE-Associated Neutropenia
-
批准号:9011147
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2016
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Genomic Fate Maps
-
批准号:7994875
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Genomic Fate Maps
-
批准号:8215841
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2008
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Genomic Fate Maps
-
批准号:8050657
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2008
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Genomic Fate Maps
-
批准号:7760668
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2008
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Genomic Fate Maps
-
批准号:7560995
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2008
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7672396
-
项目类别:
-
资助金额:$78.0万
-
财政年份:2007
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7340789
-
项目类别:
-
资助金额:$78.0万
-
财政年份:2007
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7919259
-
项目类别:
-
资助金额:$78.0万
-
财政年份:2007
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
NIH Director's Pioneer Award
-
批准号:8128696
-
项目类别:
-
资助金额:$77.22万
-
财政年份:2007
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Mistargeting of Elastase in Bone Marrow Failure
-
批准号:7105072
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2004
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Mistargeting of Elastase in Bone Marrow Failure
-
批准号:7473895
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2004
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Mistargeting of Elastase in Bone Marrow Failure
-
批准号:7277843
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2004
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Mistargeting of Elastase in Bone Marrow Failure
-
批准号:6951188
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2004
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Mistargeting of Elastase in Bone Marrow Failure
-
批准号:6874661
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2004
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Molecular Genetic Basic of Cyclic Hematopiesis
-
批准号:7883640
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2000
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
MOLECULAR GENETIC BASIS OF CYCLIC HEMATOPOIESIS
-
批准号:6897569
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2000
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
Molecular Genetic Basic of Cyclic Hematopiesis
-
批准号:7472574
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2000
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
MOLECULAR GENETIC BASIS OF CYCLIC HEMATOPOIESIS
-
批准号:6771197
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2000
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
EFFECT OF ADENOVIRUS E3 IMMUNOREGULATORY PROTEIN ON ALLOGENIC TRANSPLANTATION
-
批准号:6410335
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2000
-
负责人:MARSHALL S. HORWITZ
-
依托单位:
海外基金